medigraphic.com

2022, Number 1

<< Back

Revista Cubana de Angiología y Cirugía Vascular 2022; 23 (1)

Post-COVID-19 acute thrombotic arterial ischemia

Acosta AY

Language: Spanish
References: 8
Page: 1-8
PDF size: 265.22 Kb.


ABSTRACT

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has produced a high incidence of coagulopathy associated with an increase in morbidity and mortality in patients suffering from it. Coagulopathy is mainly thrombotic, determined by endothelial damage, inflammation, extracellular neutrophil traps, macrophage activation and cytokine storm that maintain the vicious cycle of inflammation and thrombosis. The thrombotic events observed during COVID-19 were mainly venous thromboembolic and myocardial infarction; however, the evidence showed an increase in a vascular complication that had not been described: acute peripheral arterial thrombosis. The objective of this article was to expose the infrequency of acute arterial ischemia as a form of clinical presentation of COVID-19. A 54-year-old male patient with severe pain located at the level of the right lower extremity, thermal gradient, pallor, distal cyanosis and functional impotence, with a clinical and ultrasound diagnosis of acute arterial ischemia of thrombotic cause of the right femoral and iliac arterial sector is presented. The evolution of the patient was satisfactory and he is kept under medical follow-up to evaluate the permeability of the unobstructed arterial sector.


REFERENCES

  1. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol. 2020;127:104362. DOI: https://doi.org/10.1016/j.jcv.2020.104362

  2. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9-14. DOI: https://doi.org/10.1016/j.thromres.2020.04.024

  3. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382:1708-20. DOI: https://doi.org/10.1056/NEJMoa2002032

  4. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089-98. DOI: https://doi.org/10.1007/s00134-020-06062-x

  5. Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-7. DOI: https://doi.org/10.1016/j.thromres.2020.04.013

  6. Fraissé M, Logre E, Pajot O, Mentec H, Plantefève G, Contou D. Thrombotic and hemorrhagic events in critically illOVID-19 patients: a French monocenter retrospective study. Crit Care. 2020;24(1):275. DOI: https://doi.org/10.1186/s13054-020-03025-y

  7. Kashi M, Jacquin A, Dakhil B, Zaimi R, Mahé E, Tella E, et al. Severe arterial thrombosis associated with Covid-19 infection. Thromb Res. 2020 [access 14/05/2021;192:75-7. DOI: https://doi.org/10.1016/j.thromers.2020.05.025

  8. Vulliamy P, Jacob S, Davenport RA. Acute aorto-iliac and mesenteric arterial thromboses as presenting featurtes of COVID-19. Br JHaematol. 2020 [access 14/05/2021;189(6):1053-4. DOI: https://doi.org/10.1111/bjh.16760.Epub2020May15




2020     |     www.medigraphic.com